Houlihan Lokey Advises Teijin Pharma

Teijin Pharma Limited in-licensing Japan rights for three hormone drugs from Ascendis Pharma

Buyside Advisor

Request more information regarding this transaction.

RELATED: Healthcare, Global Pharmaceuticals